European Commission wants hazardous substances law to cover devices
This article was originally published in RAJ Devices
The European Commission has proposed that medical devices and instruments used for monitoring and control generally be no longer exempt from the scope of the European directive on the restriction of hazardous substances in electrical and electronic equipment1,2. It has also proposed priority assessment of four new substances, namely the phthalates DEHP, DBP and BBP, and the flame retardant HBCDD, with a view to possibly banning their use in the future.
You may also be interested in...
For the first time, the US FDA granted an emergency use authorization to a device that allows for the home collection of saliva for COVID-19 diagnosis. See what Scott Rabuka, senior director of molecular products at DNA Genotek, which developed the test, said about it here.
Deputy CEO Nicolas Hieronimus will take L’Oreal’s helm beginning in May 2021, with Jean-Paul Agon continuing as chairman, the firm announced on 14 October. The Estee Lauder Companies hires PepsiCo’s Gibu Thomas to lead its online business, and Coty appoints its first chief digital officer.
US FDA looks to post-marketing studies to address elements of the NDA that were not central to its initial swift approval as the first COVID-19 therapy, including pediatric use and the interaction of hepatotoxicity and dose duration.